- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Most Popular Stocks
Danish Pharmaceuticals & Biotech Most Popular Stocks
Results
12
Most Popular Stocks on the market
12 companies
Novo Nordisk
Market Cap: DKK 1.7t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 388.90
7D
2.0%
1Y
-32.4%
Genmab
Market Cap: DKK 134.6b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,185.00
7D
0.1%
1Y
44.7%
ALK-Abelló
Market Cap: DKK 49.5b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 224.00
7D
-2.6%
1Y
48.6%
H. Lundbeck
Market Cap: DKK 44.7b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 46.52
7D
3.7%
1Y
15.5%
Zealand Pharma
Market Cap: DKK 29.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 419.50
7D
-0.1%
1Y
-41.2%
Bavarian Nordic
Market Cap: DKK 15.6b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 199.15
7D
0.3%
1Y
1.4%
ChemoMetec
Market Cap: DKK 12.4b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 712.00
7D
0.07%
1Y
36.4%
Gubra
Market Cap: DKK 7.7b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 474.00
7D
-7.9%
1Y
-25.5%
BioPorto
Market Cap: DKK 523.8m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.06
7D
-1.5%
1Y
-28.5%
Pharma Equity Group
Market Cap: DKK 135.6m
Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.
PEG
DKK 0.11
7D
10.5%
1Y
-34.0%
Stenocare
Market Cap: DKK 64.1m
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.
STENO
DKK 1.49
7D
-11.1%
1Y
85.6%
Strategic Partners
Market Cap: DKK 29.9m
Does not have significant operations.
STRAP
DKK 716.00
7D
-3.0%
1Y
-19.6%